Science & Enterprise subscription

Follow us on Twitter

  • A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV… https://t.co/Gl4q8GAZBg
    about 2 hours ago
  • New post on Science and Enterprise: Sensor in Works Detecting Covid-19 Airborne Virus https://t.co/gQ7LuZ5Qv1 #Science #Business
    about 2 hours ago
  • A company designing microscale robotic devices to deliver therapies to the central nervous system began work in pub… https://t.co/SUbHXwULXG
    about 4 hours ago
  • New post on Science and Enterprise: Micro Robotic Neuro Therapy Company Underway https://t.co/Lfm9Nysgd3 #Science #Business
    about 4 hours ago
  • National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
    about 1 day ago

Please share Science & Enterprise

Drug Price Disruptor Biotech Raises $500M in New Funds

Pills and dollar bill

A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round. . . . → Read More: Drug Price Disruptor Biotech Raises $500M in New Funds

Synthetic Biology Company Raises $105M in New Funds

DNA chip graphic

A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round. . . . → Read More: Synthetic Biology Company Raises $105M in New Funds

Synthetic Virus Company Forms, Raises $77M

Adenovirus schematic

A new biotechnology enterprise is underway that develops synthetic viruses attacking solid tumor cancers, based on research at the Salk Institute. . . . → Read More: Synthetic Virus Company Forms, Raises $77M

Start-Up Creating Digital Therapies for Alzheimer’s

Brain cell networks

A new enterprise is developing personalized digital therapeutics for people with Alzheimer’s disease and other neurodegenerative disorders. . . . → Read More: Start-Up Creating Digital Therapies for Alzheimer’s

Biotech Creating More Efficient Crispr Therapies

DNA puzzle

A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies

Lightweight AI Chip Designer Raises $2.8M in Seed Funds

Bumble bee and flower

A new company is designing computer chips and devices with artificial intelligence modeled on insect brains for autonomous vehicles and robotic systems. . . . → Read More: Lightweight AI Chip Designer Raises $2.8M in Seed Funds

Natural-Killer Cell Cancer Therapy Biotech Launches

Natural killer cell

A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds. . . . → Read More: Natural-Killer Cell Cancer Therapy Biotech Launches

Biotech Manufacturing, Distribution Company Underway

Vaccine vials

A new enterprise providing manufacturing and supply chain services for biotechnology labs, including gene and RNA therapy developers, began operations. . . . → Read More: Biotech Manufacturing, Distribution Company Underway

Cancer Immune System Therapy Start-Up Raises $53M

T-cells illustration

A company developing treatments that retune the immune system to kill solid tumor and blood-related cancers is raising $53 million in its first venture funding. . . . → Read More: Cancer Immune System Therapy Start-Up Raises $53M

Gene-Editing Enzyme Start-Up Gains $65M

Crispr graphic

A new company creating engineered enzymes for genome editing therapeutics is raising $65 million in its first venture funding round. . . . → Read More: Gene-Editing Enzyme Start-Up Gains $65M